Access Bio, Inc. (KOSDAQ:950130)
3,415.00
-70.00 (-2.01%)
Apr 30, 2026, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 122.58 billion as of April 30, 2026. Its market cap has decreased by -35.10% in one year.
Market Cap
122.58B
Enterprise Value
-236.27B
Revenue
31.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,415.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 122.58B, a decrease of -54.45%. That is a compound annual growth rate of -5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 120.12B | -10.13% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.39T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 14.13T |
| Amicogen | 133.16B |
| Shinhung | 129.84B |
| Osang Healthcare Co.,Ltd | 123.72B |
| iNtRON Biotechnology | 119.66B |